![Matthew Pearson](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3266396/a5da7390-f0f0-4f40-aa2a-73fc4e7913f5/profile.png)
Matthew Pearson
USA Guide 2024
Band 4 : Intellectual Property
Share profile
Band 4
About
Provided by Matthew Pearson
Practice Areas
Dr. Pearson’s practice focuses on patent litigation, representing numerous key industry players in pharmaceuticals, chemistry and biology, with a particular focus on biologics and antibody technology. He holds a Ph.D. in biochemistry and, before transitioning to law, worked at the National Institutes of Health. His scientific background has allowed him to successfully litigate major patent disputes involving biologics, an extremely competitive and technically complex field.
Intellectual Property: Patent Litigation; Life Sciences; Strategic IP Counseling; Inter Partes Review; Supreme Court & Appellate: IP
Publications
Frequent speaker on patent litigation, biologics and biosimilars.
Personal
J.D., University of Pennsylvania Law School, summa cum laude, 2005
Ph.D., Cornell University, 1999
B.S., Michigan State University, with high honors, 1993
Adjunct professor, University of Pennsylvania Law School, patent litigation.
Discover other Lawyers at
Akin
California
![Chris Spicer](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3273884/86a53362-1eae-4154-bcdd-4084e8b623ea/profile.png)
![Marissa Román Griffith](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3273647/e36a85b4-f66a-4f9d-b261-4365b44c0c15/profile.png)
![Alissa Miller](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3271478/7eded483-4604-45df-9ede-a227e1be4626/profile.png)
District of Columbia
![Robert S Salcido](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3275719/f889204b-cb79-4681-b919-8feb8d8cbf13/profile.png)
![John Jacob](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3169787/be698f10-2131-42c2-ba31-332a3983f3ee/profile.png)
![Kelly Cleary](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3169971/cf18ac74-f0d0-4829-ad84-39f6c3b67659/profile.png)
![Charles Connolly](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3179817/ac1f37f0-b214-4199-8b2c-80a6efb07c19/profile.png)
![Paul Butler](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3179769/b84eba9c-50dc-4b9a-8509-b559cba03f3a/profile.png)
![Claudius Modesti](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3277248/0fe595eb-b4bd-4e40-acc0-12586f109681/profile.png)